The estrogen receptor ERα was shown to be downregulated by transfection with miR-22 in endometrioid carcinomas, where continuous stimulation by estrogen is considered a risk factor for tumorigenesis (Li and Yang, 2013). Here, ESR1 is linked to endometrioid adenocarcinoma.